Results 31 to 40 of about 4,105,314 (99)

Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC) [PDF]

open access: yes, 2019
Aims: In this study, we investigated whether free intraperitoneal tumour cells (FITC) were detectable in ascites or peritoneal lavage fluid (PLF) from patients with peritoneal metastasis (PM) before and after treatment with pressurised intraperitoneal ...
Kristensen, Thomas Kielsgaard   +6 more
core   +1 more source

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial). [PDF]

open access: yesAnn Surg Oncol, 2023
Background: We aimed to investigate the therapeutic efficacy and safety of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in platinum-resistant recurrence of ovarian cancer and peritoneal carcinomatosis, while our secondary endpoint was to ...
Vizzielli G   +11 more
europepmc   +3 more sources

Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis

open access: yes, 2020
Background: Few patients affected by gastric cancer peritoneal metastasis (GCPM) are offered locoregional treatment, despite several proof-of-efficacy trials.
Strippoli A.   +10 more
core   +2 more sources

Pressurised Intraperitoneal Aerosolised Chemotherapy-Results from the First Hundred Consecutive Procedures. [PDF]

open access: yesCancers (Basel)
PIPAC is a new and promising technique for the intraperitoneal administration of chemotherapy. It can be used in patients with various peritoneal cancer metastases.
Hoskovec D   +4 more
europepmc   +2 more sources

Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey

open access: yes, 2018
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new laparoscopic administration of chemotherapy for peritoneal metastasis (PM). PIPAC is repeated every 5th week, and seems to stabilize or improve quality of life, and might improve survival.
M. Graversen   +14 more
core   +1 more source

Reliability of Pterygium Redness Grading Software (PRGS) in describing different types of primary pterygia based on appearance = Kebolehpercayaan Perisian Penggredan Kemerahan Pterigium (PRGS) dalam mengelaskan pelbagai jenis pterigium berdasarkan perawakan [PDF]

open access: yes, 2020
he aim of this study was to evaluate the reliability of Pterygium Redness Grading Software (PRGS) in describing different types of primary pterygia. Ninety-three participants with primary pterygia who visited an ophthalmology clinic were recruited in ...
Che Azemin, Mohd Zulfaezal   +5 more
core   +2 more sources

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer:a descriptive cohort study

open access: yes, 2020
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) represents a novel approach to deliver intraperitoneal chemotherapy. We report our experience with PIPAC in patients with peritoneal metastasis (PM) from gastric cancer (GC). Data from GC patients (
Lundell, L,   +12 more
core   +1 more source

Logistic regression for simulating damage occurrence on a fruit grading line [PDF]

open access: yes, 2003
Many factors influence the incidence of mechanical damage in fruit handled on a grading line. This makes it difficult to address damage estimation from an analytical point of view.
Bielza Lozoya, Maria Concepcion   +3 more
core   +1 more source

UEG Week 2017 Poster Presentations

open access: yes, 2017
United European Gastroenterology Journal, Volume 5, Issue S5, Page A161-A836, October 2017.
wiley   +1 more source

Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy – PIPAC-OPC2 [PDF]

open access: yes, 2018
BackgroundPeritoneal carcinomatosis (PC) is a common endpoint in both gastrointestinal and non-gastrointestinal cancers, and PC is treated as other systemic metastases – unfortunately with disappointing results and considerable side-effects.
Per Pfeiffer   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy